Skip to main content
Lippincott Open Access logoLink to Lippincott Open Access
. 2025 Oct 6;63(6):458–465. doi: 10.1097/IO9.0000000000000325

A cross-sectional study of demographic profile and incidence of Helicobacter pylori in patients with duodenal ulcer perforation

Samrat Shrestha a,*, Mecklina Shrestha b, Bijay Raj Bhatta a, Suresh Maharjan a, Kaushal Samsher Thapa a, Ghanashyam Thapa a, Kishor Manandhar a
PMCID: PMC12662151  PMID: 41323429

Abstract

Introduction:

Duodenal ulcer Perforation (DUP) is a life-threatening complication of peptic ulcer disease, disproportionately burdening resource-limited regions. Helicobacter pylori (H. pylori) is a key etiology, yet data from Nepal are limited. This study evaluated demographics, risk factors, and H. pylori incidence in DUP patients at a Nepalese tertiary center.

Methods:

A hospital-based prospective cross-sectional study (March 2024–April 2025) included 61 surgically managed DUP patients aged 18–70 years. Exclusion criteria: recent antibiotic/proton pump inhibitors use, gastric ulcers, or traumatic perforation. H. pylori was detected via histopathological analysis of perforation margin biopsies. Demographics, risk factors [smoking, alcohol, nonsteroidal anti-inflammatory drugs (NSAIDs), steroids, socioeconomic status (SES), food habits], and outcomes were analyzed using SPSS v28 (χ2/t-tests; P < 0.05 significant).

Results:

The cohort (mean age 38.7 ± 17.6 years; 93% male) showed 65.57% H. pylori positivity. Smoking prevalence was 82% and significantly associated with H. pylori infection (OR = 4.50, 95% CI: 1.14–17.8; P = 0.024). Low SES (57% of patients) correlated strongly with H. pylori, whereas high or middle socioeconomic status had significantly lower odds of H. pylori infection (high/middle SES OR = 0.30, 95% CI: 0.10–0.89; P = 0.027). Alcohol use (59%) had a nonsignificant H. pylori association (OR = 2.78, 95% CI: 0.93–8.26; P = 0.063), while NSAIDs (8%) and steroids (7%) played minimal roles.

Conclusion:

DUP in Nepal predominantly affects young males, with high H. pylori prevalence (65.57%) driven significantly by smoking and low SES. These findings highlight synergistic sociodemographic and biological risk factors in resource-limited South Asia, advocating for targeted H. pylori screening and prevention programs.

Keywords: cross-sectional study, duodenal ulcer, Helicobacter pylori, histopathology, perforation, smoking, socioeconomic status

Introduction

Peptic ulcer disease (PUD) remains a major global health burden, with more than 8 million cases reported annually worldwide and a lifetime risk of PUD of 5–10%[1,2]. Duodenal ulcers (DU) comprise a large proportion of PUD and are associated with significant complications, with perforation as the most life-threatening. Over the past 50 years, the epidemiology of PUD has shifted significantly. In high-income countries, improved hygiene and widespread use of proton pump inhibitors have led to a decline in Helicobacter pylori (H. pylori) infections, a primary cause of PUD. Conversely, in low- and middle-income countries, the median age at diagnosis has risen from the mid-30s–40s to 60 years and older, and the male-to-female ratio has narrowed from a previous 4–5:1 to nearly 1:1. Additionally, there has been a shift from predominantly DU to a higher incidence of gastric ulcers, possibly due to increased nonsteroidal anti-inflammatory drugs (NSAID) usage and an aging population[3]. Various cohorts from Africa, South Asia, and the Middle East reported that PUD is more common in males and 6–13 times higher than in females, with up to 90% of cases, the predominant site of perforation being the bulb of the duodenum[2]. Perforated peptic ulcers (PPUs) affect 2–10% of PUD patients and are associated with mortality rates ranging from 10% to 20%[3,4].

PPU, a severe complication of PUD, occurs in approximately 2–14% of cases. The lifetime risk of perforation among PUD patients is estimated at around 5%. PPU often presents as an acute abdomen and is associated with significant morbidity and mortality, with reported mortality rates ranging from 1.3% to 20%. Notably, 30-day mortality can reach up to 20%, and 90-day mortality rates have been reported as high as 30%[4]. The burden of these complications is disproportionately high in developing countries, particularly in South Asia, due to limited healthcare access, delayed presentation, and socioeconomic constraints[5].

H. pylori, discovered in 1982 by Barry Marshall and Robin Warren, is a spiral, gram-negative, microaerophilic bacterium implicated in the pathogenesis of PUD and its complications[6,7]. H. pylori infection involves three stages: gastric colonization, immune activation, and disease. Crucially, urease hydrolyzes urea into ammonia, neutralizing stomach acid locally and enabling survival. This pH shift thins the mucus layer, allowing bacterial movement to colonization sites like gastric pits. Further pathogenesis relies on key virulence factors: adhesins for attachment, toxins (like CagA and VacA) that damage host cells, and mechanisms altering the local environment for persistence[6].

H. pylori is a primary cause of DU. It disrupts normal acid regulation, causing hypersecretion that damages the duodenum and synergizes with ulcer formation. Consequently, DU patients have significantly higher H. pylori infection rates than the general population, often involving virulent strains (like CagA+). Evidence shows H. pylori contributes to DU pathogenesis in 84.9% of cases and is the sole cause in 44.1%. It confers a very high relative risk (RR = 51) for DU development. A pre-existing H. pylori infection is a major risk factor itself. Crucially, when NSAID/antibiotic users are excluded, H. pylori prevalence in DU patients rises dramatically to 99.1%, solidifying its causal role, especially in non-NSAID-induced ulcers and complications like perforation[8]. A study by Chu et al found that H. pylori infection is linked to recurrent ulcers in patients with a history of DU perforation (DUP)[9].

While population-wide screening for H. pylori is often impractical in resource-limited settings, a targeted “test-and-treat” strategy focused on high-risk demographic groups presents a more feasible public health intervention. The critical challenge lies in clearly defining this high-risk cohort based on local epidemiological data. Furthermore, the success of such a strategy hinges on employing diagnostic methods that are not only accurate but also cost-effective and readily integrable into existing clinical pathways. This study aims to identify the key demographic and risk factors associated with H. pylori-positive DUP, thereby providing the necessary evidence base to define a target population for screening and to inform a practical and sustainable prevention strategy[10].

Given these gaps, this study was undertaken to evaluate the demographic, clinical profile, and incidence of H. pylori among patients presenting with DUP in a tertiary care center in Nepal over a 1-year period. H. pylori detection was performed using histological analysis from biopsies of the perforation margin. The findings aim to strengthen understanding of the regional burden of H. pylori-associated ulcer complications and guide appropriate clinical management. This cross-sectional study has been reported in line with the Strengthening the Reporting of Cohort Studies in Surgery (STROCSS) guidelines, 2025[11].

Materials and methods

Study design

This study is a hospital-based, prospective, analytical cross-sectional study conducted at the Department of General Surgery in a tertiary center of Kathmandu, Nepal, from 1 March 2024 to 30 April 2025. Patients aged 18–70 years with DUP who underwent surgery were included in this study. Exclusion criteria were patients younger than 18 or older than 70 years, recent use of antibiotics, PPIs, or H2-receptor antagonists within 4 weeks before admission, gastric ulcers or malignancy-related perforation, hollow viscus perforation other than DUP, or traumatic duodenal perforation. Demographic data, including age, sex, and various etiological factors, including smoking, alcohol consumption, NSAIDs, socioeconomic status, steroids, and food habits, were collected. Upon presentation to the emergency room (ER), patients underwent initial evaluation, including vital sign assessment. Hematological and biochemical investigations were performed. An erect chest X-ray was done in all patients to assess for pneumoperitoneum. Following diagnosis, all patients were promptly resuscitated. Informed consent was obtained from patients or their representatives for surgical exploration. Patients were taken for emergency exploratory laparotomy. Intravenous ceftriaxone (1 g) was administered at the time of induction of anesthesia. A definitive diagnosis of DUP was made intraoperatively. Perforation size and site noted. Two mucosal biopsies were obtained from the perforation edge at 3 and 9 o’clock positions. Peritoneal lavage with warm saline was performed, and perforation was repaired with a pedicled omental patch. The abdomen was closed in layers. All the patients who had positive histopathological detection of H. pylori were given the H. pylori eradication therapy.

Statistical analysis

Data entered in Microsoft Excel 365 and analyzed using SPSS v28. Continuous variables were expressed as mean ± standard deviation and compared using the Student’s t-test or the Mann–Whitney U test. Categorical variables were presented as frequencies and percentages and compared using the Chi-square (χ²) or Fisher’s Exact test. A P-value of < 0.05 was considered statistically significant.

Result

A total of 61 patients with DUP were enrolled in the study. The mean age was 38.66 ± 17.64 years. The majority of patients were in the 21–30 years age group (n = 16, 26.22%), and the H. pylori infection was more prevalent in the 21–30 year age group, accounting for 16.39% of all cases (Table 1, Fig. 1). The cohort was predominantly male, comprising 93.45% (n = 57) of the patients, with a male: female ratio of 14.25:1 (Table 2, Fig. 2).

Table 1.

Age-wise distribution of H. pylori positivity on histopathological examination (HPE)

Age distribution H. pylori on HPE Total
Positive Incidence Negative Incidence
18–20 years 7 11.48% 3 4.92% 10
21–30 years 10 16.39% 6 9.84% 16
31–40 years 9 14.75% 5 8.20% 14
41–50 years 2 3.28% 1 1.64% 3
51–60 years 3 4.92% 3 4.92% 6
61–70 years 9 14.75% 3 4.92% 12

Figure 1.

Figure 1.

Bar graph showing age-wise distribution of H. pylori infection.

Table 2.

Sex-wise distribution of H. pylori positivity on histopathological examination (HPE)

Sex H. pylori on HPE Total
Positive Incidence Negative Incidence
Male 37 60.66% 20 32.79% 57
Female 3 4.92% 1 1.64% 4

Figure 2.

Figure 2.

Bar graph showing sex-wise distribution of H. pylori infection.

Among 61 patients, 81.97% (n = 50) were smokers, and 18.03% (n = 11) were nonsmokers. Alcohol consumption was reported by 59.02% (n = 36) of the patients. Chronic NSAID use was documented in 8.20% (n = 5) of cases. Four patients (6.56%) used steroids for other chronic conditions. Regarding socioeconomic status (SES), 57.38% (n = 35) belonged to the lower SES group, 39.34% (n = 24) to the middle SES, and 3.28% (n = 2) to the upper SES. 29.51% (n = 18) of patients had a history of irregular food habits (Table 3).

Table 3.

Association of risk factors with H. pylori status and statistical analysis

Risk factor H. pylori status Total Statistical value
Positive Negative
Smoking
 Present 36 14 50 χ2 = 5.09, df − 1
 Absent 4 7 11 P = 0.024
Alcohol
 Present 27 9 36 χ2 = 3.45, df − 1
 Absent 13 12 25 P = 0.063
NSAIDs
 Present 4 1 5 χ2 = 0.50, df − 1
 Absent 36 20 56 P = 0.48
Steroid use
 Present 3 1 4 χ2 = 0.17, df − 1
 Absent 37 20 57 P = 0.68
Socioeconomic status
 High and middle 13 13 26 χ2 = 4.86, df − 1
 Low 27 8 35 P = 0.027
Irregular food habits
 Present 9 9 18 χ2 = 2.74, df − 1
 Absent 31 12 43 P = 0.097

On univariate analysis, smoking was significantly associated with H. pylori positivity (36/50 in smokers vs. 4/11 in nonsmokers; χ2 = 5.09, df = 1; P = 0.024), as was low socioeconomic status (27/35 in low SES vs. 13/26 in high and middle SES; χ2 = 4.86, df = 1; P = 0.027) (Table 3). Alcohol use showed a trend toward higher infection rates (27/36 in alcohol consumers vs. 13/25 in nonalcohol consumers), however, alcohol (P = 0.063), NSAID use (P = 0.48), steroid therapy (P = 0.68), and irregular food habits (P = 0.097) were not significantly linked to H. pylori status (Table 3).

Clinical presentation and investigations

All patients (n = 61) presented with abdominal pain and exhibited abdominal tenderness on clinical examination. The most prevalent associated symptoms were vomiting (n = 35, 57.4%) and abdominal distention (n = 34, 55.7%). Nausea was reported in 29 patients (47.5%). A history of fever was uncommon (n = 4, 6.6%) (Table 4, Fig. 3). Beyond generalized tenderness (n = 61, 100%), rebound tenderness was elicited in 49 patients (80.3%), abdominal guarding in 36 patients (59.0%), and rigidity in 23 patients (37.7%) (Table 5, Fig. 4).

Table 4.

Frequency and percentage distribution of presenting symptoms

Variable
Symptoms Frequency Percentage
Abdominal pain
 Present 61 100%
 Absent 0 0%
Nausea
 Present 29 47.54
 Absent 32 52.46
Vomiting
 Present 35 57.38%
 Absent 26 42.62%
Fever
 Present 4 6.56%
 Absent 57 93.44%
Abdominal distention
 Present 34 55.74%
 Absent 27 44.26%

Figure 3.

Figure 3.

Bar graph showing the frequency of presenting symptoms in patients with duodenal ulcer perforation.

Table 5.

Frequency and percentage distribution of observed signs

Variable
Signs Frequency Percentage
Tenderness
 Present 61 100%
 Absent 0 0%
Rebound tenderness
 Present 49 80.33%
 Absent 12 19.67%
Guarding
 Present 36 59.02%
 Absent 25 40.98%
Rigidity
 Present 23 37.70%
 Absent 28 45.90%
Preoperative total leukocyte count
 <4000/ cu.mm 7 11.48%
 4000–11 000/cu·mm 27 44.26%
 >11 000/cu mm 27 44.26%

Figure 4.

Figure 4.

Bar graph showing frequency of clinical signs in patients with duodenal ulcer perforation.

Laboratory findings

Analysis of total leukocyte counts revealed leukocytosis (≥11 000/mm3) in 27 patients (44.3%). Leukopenia (<4000/mm3) was observed in 7 patients (11.5%), while 27 patients (44.3%) had counts within the normal reference range (4000–11 000/mm3) (Table 5).

Radiological investigations

Chest radiography was performed on all patients. Pneumoperitoneum was detected radiographically (in an erect chest X-ray) in 58 patients (95.1%). The remaining three patients (4.9%) with normal chest X-rays underwent contrast-enhanced computed tomography (CECT) of the abdomen, which subsequently confirmed pneumoperitoneum in all cases.

Perforation characteristics and histopathological detection of H. pylori

All patients underwent classical Graham patch repair, with perforations located at the first part of the duodenum in 100% of cases (n = 61). Among them, 44 patients (72.13%) had perforations measuring less than 10 mm, while 17 patients (27.87%) had perforations ≥10 mm. The mean perforation size was 6.21 ± 2.99 mm. The sensitivity of erect chest X-ray (CXR) in detecting pneumoperitoneum was 85.71% for perforations measuring 1–4 mm, 96.77% for those measuring 5–9 mm, and 100% for perforations measuring ≥10 mm. This increase in sensitivity with larger perforations can be attributed to the greater amount of free intraperitoneal air escaping through larger defects, making radiographic detection more likely. Mucosal biopsies from the perforation margins were obtained in all patients. Histopathological examination using Giemsa stain revealed H. pylori infection in 65.57% of cases (n = 40) (Table 6, Fig. 5).

Table 6.

Site-wise distribution of H. pylori status on histopathological examination (HPE)

Site H. pylori status on HPE Total
Positive Percentage Negative Percentage
Duodenal ulcer perforation 40 65.57% 21 34.43% 61 (100%)

Figure 5.

Figure 5.

Pie chart showing H. pylori status in patients with duodenal ulcer perforation.

Discussion

Demographic patterns

In our study, most patients were young (mean age ~39 years) and predominantly male (>93%). This mirrors Agrawal’s report (mean age 40, 92% male) and aligns with the general pattern in South Asia[12]. In developing countries, peptic ulcer perforations still occur most often in young men. In contrast, in high-income settings, the median age of ulcer patients has risen into the 60s, and the male: female ratio has narrowed toward 1:1. Thus, our findings (young male predominance) are consistent with other regional data, even as global trends reflect an aging patient population[4].

Risk factors

Common ulcer risk factors were prevalent in our study. In particular, smoking and alcohol use were very common. In our study, 82% of patients were smokers, and 59% reported regular alcohol intake. Similarly, Agrawal et al[12] found that 48% of patients smoked and 64% drank alcohol before perforation. These exposures likely contribute to the male predominance. Smoking is a well-known risk factor for ulcers and is very common in young males with DUP[12]. Most recent studies of perforated ulcers in low-resource settings involve smokers. Nicotine stimulates gastric acid secretion, and bicarbonate secretion is inhibited by smoking. Smoking has been strongly associated with DU perforation in individuals younger than 75 years of age[3]. Notably, smoking was significantly associated with H. pylori positivity in our data (P = 0.024), and smoking was associated with increased odds of being H. pylori positive (OR = 4.50; 95% CI: 1.14–17.8). A case-control study conducted by Mhaskar et al identified smoking as a significant risk factor for H. pylori infection, with an odds ratio of 2.23 (95% CI: 1.24–4.02). This finding aligns with other research indicating that smoking can increase the risk of H. pylori infection and may contribute to PUD[13]. Alcohol compromises mucosal integrity and exacerbates ulcer risk, though it is not an independent risk factor for H. pylori infection[4]. In our study, alcohol consumption was associated with higher odds of H. pylori positivity (OR = 2.78; 95% CI: 0.93–8.26). However, this association was not statistically significant (P < 0.063). In a study by Dogra et al 64% of the patients were smokers, and 40% had a history of alcohol consumption[14]. A 2016 dose–response meta-analysis of 12 observational studies found that moderate alcohol consumption was associated with a lower risk of H. pylori infection (OR = 0.78, 95% CI: 0.69–0.89), with similar protective trends even at higher intake levels (up to 96 g/d)[15].

NSAIDS inhibit the synthesis of prostaglandin, leading to reduced mucus secretion and increased gastric acid production[3]. Our study showed that only 8% of the patients had chronic NSAID use. Unlike Western cohorts, NSAID-driven PPU is uncommon in this setting. Globally, chronic NSAIDs are a recognized PPU risk, but they play a minor role in our population[4].

Corticosteroid use is also a recognized risk factor for PPU[16]. Corticosteroid therapy compromises gastrointestinal mucosal defenses – primarily by inhibiting prostaglandin synthesis – thus increasing the risk of DU formation, bleeding, and perforation by 40% (OR ≈ 1.4)[17]. This risk increased substantially with concurrent corticosteroids and NSAIDs (additive OR ≈ 4.0)[18]. However, in our study of 61 patients, 4 (6.6%) were corticosteroid users; among these, 3 (75%) tested positive for H. pylori. The association between steroid use and H. pylori infection in patients with DU perforation was not statistically significant (P = 0.17). This is likely due to low statistical power. Nevertheless, our H. pylori prevalence among steroid users (75%) aligns with larger series reporting 50–80% infection rates in PPUs[4]. Thus, while our results are inconclusive, they do not conflict with established evidence and underscore the need for larger, adequately powered studies.

In our study, most patients were from lower socioeconomic strata, and low SES was significantly associated with H. pylori infection (P = 0.027). Low SES strongly correlates with H. pylori infection due to overcrowding, poor sanitation, and limited healthcare access. Individuals with lower education and physically demanding jobs may also have higher physiological stress, increasing ulcer risk. In contrast, those with higher SES are more likely to use gastroprotective medications, reducing complications like perforation[19]. Our study showed patients from high or middle socioeconomic status had significantly lower odds of H. pylori infection compared to those from low socioeconomic status (OR = 0.30; 95% CI: 0.10–0.89), indicating that low SES may be a significant risk factor. This corroborates the established link between poverty, poor sanitation, and early-life H. pylori transmission[19]. In a case-control study conducted by Mhaskar et al lower SES was a significant risk factor for H. pylori infection (OR = 1.10, 95% CI 1.02–1.39)[13].

Regularly altering mealtimes appears to substantially increase the likelihood of developing H. pylori infection and gastritis[20]. The association between prolonged fasting, skipping meals, and DUP may be linked to sustained gastric acid exposure without adequate neutralization. This can weaken the gastric mucosal defense, predisposing to ulcer formation and eventual perforation. In one study by Bose et al, nearly 60% of patients with gastroduodenal perforation reported a history of frequent spicy food consumption[21]. In our study, irregular eating patterns showed no significant association with H. pylori positivity among patients with DUP. An equal number tested positive and negative in the irregular eating group (9 vs. 9), indicating no clear link between meal pattern and infection status. Overall, the risk profile in our series (high smoking and alcohol rates in young men, lower socioeconomic status) matches other South Asian reports. These factors synergize with H. pylori to precipitate ulcer perforation[4].

In our study, H. pylori was detected histologically in a majority of cases of DU perforation (65.57%; 40/61 patients). This rate aligns with recent South Asian reports. For example, Agrawal et al found H. pylori in 58% of DUP in Nepal, and Bose et al reported 85% positivity in rural India[12,21]. In global series, histology-based studies typically show ~50–90% H. pylori detection in DUP.[3,4] Collectively, these findings indicate that most DUP in our region harbor H. pylori, and infection rates can vary widely depending on local patient factors and diagnostic methods. The comparative analysis of nine studies, including our own, shows a variable prevalence of H. pylori in patients with DUP, ranging from 46.9% to 92% (Table 7)[9,12,13,22–26]. Earlier studies, such as Reinbach (1993) and Chu (1999), reported lower positivity rates (~47%), while more recent investigations, including Dogra (2014) and Agrawal (2019), reported significantly higher rates (92% and 58% respectively)[9,12,13,22]. Our study demonstrated a positivity rate of 65.57%, aligning with the mid-to-high end of the reported spectrum. This suggests persistent regional heterogeneity, likely influenced by diagnostic techniques, antibiotic exposure, and population-level risk factors.

Table 7.

Comparison of H. pylori positivity rates across studies (Including current study data)

Author Year Number of patients H. pylori positive
Reinbach[22] 1993 80 47%
Debongnie[23] 1995 36 56%
Chu[9] 1999 163 47.2%
Ng[24] 2000 129 81%
Sharma[25] 2000 44 61%
Dogra[14] 2014 50 92%
John[26] 2017 113 46.9%
Agrawal[12] 2019 50 58%
Our study 2024 61 65.57%

Conclusion

Our findings confirm that DUP in Nepal predominantly affects young males with significant risk factors like smoking and low SES. These findings support the implementation of targeted H. pylori screening in high-risk groups – particularly young male smokers and patients from disadvantaged backgrounds – which could enhance early detection and tailored eradication therapy. Clinicians should consider routine histology and rapid urease testing (a low-cost and rapid method) intraoperatively to guide postoperative management and reduce recurrence. While further research is needed to assess long-term cost-effectiveness, prioritizing such groups may represent a pragmatic and economically sensible approach in resource-limited South Asian settings. At the public health level, smoking-cessation initiatives and socioeconomic upliftment programs may indirectly curb H. pylori burden and its complications. The demographic and risk profiles align with regional patterns in South Asia but contrast with Western trends of older patients and higher NSAID involvement. These findings underscore the critical role of H. pylori, smoking, and socioeconomic factors in driving DUP in resource-limited settings, underscoring the need for targeted prevention strategies and optimized clinical management in these populations.

Footnotes

Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.

Published online 6 October 2025

Contributor Information

Samrat Shrestha, Email: samratshrestha431@gmail.com.

Mecklina Shrestha, Email: sthamecklina@gmail.com.

Bijay Raj Bhatta, Email: schizophrenicbj995@gmail.com.

Suresh Maharjan, Email: sureshmaharjan89@gmail.com.

Kaushal Samsher Thapa, Email: samsherthapa2050@gmail.com.

Ghanashyam Thapa, Email: saudagi9@gmail.com.

Ethical approval

Ethical clearance for this study was obtained from the Institutional Review Committee. The purpose of the study was clearly explained to each participant or their attendant, and written informed consent was obtained before inclusion. Patients were assured of their right to decline or withdraw from the study at any stage without affecting their care.

Consent

Written informed consent was obtained before inclusion.

Sources of funding

No specific grant or funding was received from any funding agency in the public, commercial, or not-for-profit sectors for this research.

Author contributions

All authors contributed significantly to the work. All authors contributed to data interpretation, critical revision of the manuscript, and final approval of the version to be published. All authors read and approved the final manuscript.

Conflicts of interest disclosure

The authors declare no competing interests.

Guarantor

Samrat Shrestha.

Research registration unique identifying number (UIN)

None.

Provenance and peer review

Not commissioned, externally peer reviewed.

Data availability statement

All relevant data generated or analyzed during this study are included in this published article. Additional datasets are available from the corresponding author on reasonable request.

Acknowledgements

Not applicable.

References

  • [1].Malik TF, Gnanapandithan K, Singh K. Peptic ulcer disease. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2025. https://www.ncbi.nlm.nih.gov/books/NBK534792/ [PubMed] [Google Scholar]
  • [2].Sung JJY, Kuipers EJ, El-Serag HB. Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther 2009;29:938–46. [DOI] [PubMed] [Google Scholar]
  • [3].Søreide K, Thorsen K, Harrison EM, et al. Perforated peptic ulcer. Lancet 2015;386:1288–98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].Chung KT, Shelat VG. Perforated peptic ulcer - an update. World J Gastrointestinal Surg 2017;9:1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [5].Xie X, Ren K, Zhou Z, et al. The global, regional and national burden of peptic ulcer disease from 1990 to 2019: a population-based study. BMC Gastroenterol 2022;22:58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [6].Elbehiry A, Marzouk E, Aldubaib M, et al. Helicobacter pylori infection: current status and future prospects on diagnostic, therapeutic, and control challenges. Antibiotics 2023;12:191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [7].Kusters JG, Van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006;19:449–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].Ahmed S, Belayneh YM. Helicobacter pylori and duodenal ulcer: systematic review of controversies in causation. Clin Exp Gastroenterol 2019;12:441–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [9].Chu KM, Kwok KF, Law SYK, et al. Helicobacter pylori status and endoscopy follow-up of patients having a history of perforated duodenal ulcer. Gastrointest Endosc 1999;50:58–62. [DOI] [PubMed] [Google Scholar]
  • [10].Malfertheiner P, Megraud F, Rokkas T, et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut 2022;71:1724–62. [DOI] [PubMed] [Google Scholar]
  • [11].Agha R, Mathew G, Rashid R, et al. Revised strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) guideline: an update for the age of artificial intelligence. Prem J Sci 2025;10:100081. [Google Scholar]
  • [12].Agrawal S, Thakur D, Kafle P, et al. Association of Helicobacter pylori with peptic ulcer perforation. J BP Koirala Institute Health Sci 2019;2:4–10. [Google Scholar]
  • [13].Mhaskar R, Ricardo I, Azliyati A, et al. Assessment of risk factors of Helicobacter pylori infection and peptic ulcer disease. J Global Infect Dis 2013;5:60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14].Dogra B, Panchabhai S, Rejinthal S, et al. Helicobacter pylori in gastroduodenal perforation. Med J Dr D Y Patil Univ 2014;7:170. [Google Scholar]
  • [15].Liu SY, Han XC, Sun J, et al. Alcohol intake and Helicobacter pylori infection: a dose–response meta-analysis of observational studies. Infect Dis 2015;48:303–09. [DOI] [PubMed] [Google Scholar]
  • [16].Amini A, Lopez RA. Duodenal perforation. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2025. https://www.ncbi.nlm.nih.gov/books/NBK553084/ [PubMed] [Google Scholar]
  • [17].Narum S, Westergren T, Klemp M. Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis. BMJ Open 2014;4:e004587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [18].Hernandez-Diaz S. Steroids and risk of upper gastrointestinal complications. Am J Epidemiol 2001;153:1089–93. [DOI] [PubMed] [Google Scholar]
  • [19].Hombal P, Gudadappanavar A. Duodenal perforations in the era of PPI; is lower socioeconomic status risk factor for peptic ulcer perforation? A Case Series. Int J Surg Med 2025;1:1. [Google Scholar]
  • [20].Lim SL, Canavarro C, Zaw MH, et al. Irregular meal timing is associated with Helicobacter pylori infection and gastritis. ISRN Nutr 2012;2013:1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21].Bose G, Ray A, Ali SN, Ishore K. Profile of gastroduodenal perforation patients admitted in a rural tertiary care hospital: an observational cross-sectional study. J West Afr Coll Surgeons 2024;14:289–94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [22].Reinbach DH, Cruickshank G, McColl KE. Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut 1993;34:1344–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].Debongnie JC, Wibin E, Timmermans M, Mairesse J. Dekoninck X Are perforated gastroduodenal ulcers related to Helicobacter pylori infection? Acta Gastro-Enterologica Belg 1995;58:208–12. [PubMed] [Google Scholar]
  • [24].Ekw N, Lam YH, Sung JJY, et al. Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation. Ann Surg 2000;231:153–58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [25].Sharma AK, Mittal S, Malvi SK. Association of Helicobacter pylori with peptic perforation in Chattisgarh region of India. Trop Gastroenterol 2000;21:42–43. [PubMed] [Google Scholar]
  • [26].John B, Mathew BP, Chandran V. Prevalence of Helicobacter pylori in peptic ulcer perforation. Inter Surg J 2017;4:3350. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All relevant data generated or analyzed during this study are included in this published article. Additional datasets are available from the corresponding author on reasonable request.


Articles from International Journal of Surgery Open are provided here courtesy of Wolters Kluwer Health

RESOURCES